I
Imunon D
D
IMNN
1.02000
USD
-0.11
(-9.73%)
مغلق
حجم التداول
58,683
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
20,725,901
العنوان: Imunon
القطاع: Healthcare
الصناعة: Biotechnology
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting adifferentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).